Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'MASH DC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hurley, MJ; Mash, DC; Jenner, P
      Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease

      MOLECULAR BRAIN RESEARCH
    2. Baumann, MH; Rothman, RB; Pablo, JP; Mash, DC
      In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Eshleman, AJ; Wolfrum, K; Mash, DC; Christensen, K; Janowsky, A
      Drug interactions with the dopamine transporter in cryopreserved human caudate

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Mash, DC; Staley, JK; Izenwasser, S; Basile, M; Ruttenber, AJ
      Serotonin transporters upregulate with chronic cocaine use

      JOURNAL OF CHEMICAL NEUROANATOMY
    5. Hurley, MJ; Mash, DC; Jenner, P
      Adenosine A(2A) receptor mRNA expression in Parkinson's disease

      NEUROSCIENCE LETTERS
    6. Wang, YH; TesFaye, E; Yasuda, RP; Mash, DC; Armstrong, DM; Wolfe, BB
      Effects of post-mortem delay on subunits of ionotropic glutamate receptorsin human brain

      MOLECULAR BRAIN RESEARCH
    7. Mufson, EJ; Deecher, DC; Basile, M; Izenwasse, S; Mash, DC
      Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis

      NEUROPHARMACOLOGY
    8. Mash, DC; Kramer, LC; Segal, D; Izenwasser, S
      Dopamine transporter mRNA in human brain - Distribution and regulatory effects in autopsy studies of cocaine abusers

      CEREBRAL SIGNAL TRANSDUCTION
    9. Zubaran, C; Shoaib, M; Stolerman, IP; Pablo, J; Mash, DC
      Noribogaine generalization to the ibogaine stimulus: Correlation with noribogaine concentration in rat brain

      NEUROPSYCHOPHARMACOLOGY
    10. Callaway, JC; McKenna, DJ; Grob, CS; Brito, GS; Raymon, LP; Poland, RE; Andrade, EN; Andrade, EO; Mash, DC
      Pharmacokinetics of Hoasca alkaloids in healthy humans

      JOURNAL OF ETHNOPHARMACOLOGY
    11. Chen, L; Segal, DM; Moraes, CT; Mash, DC
      Dopamine transporter mRNA in autopsy studies of chronic cocaine users

      MOLECULAR BRAIN RESEARCH
    12. Izenwasser, S; Staley, JK; Cohn, S; Mash, DC
      Characterization of kappa(1)-opioid receptor binding in human insular cortex

      LIFE SCIENCES
    13. Ma, SY; Ciliax, BJ; Stebbins, G; Jaffar, S; Joyce, JN; Cochran, EJ; Kordower, JH; Mash, DC; Levey, AI; Mufson, EJ
      Dopamine transporter-immunoreactive neurons decrease with age in the humansubstantia nigra

      JOURNAL OF COMPARATIVE NEUROLOGY
    14. Ciliax, BJ; Drash, GW; Staley, JK; Haber, S; Mobley, CJ; Miller, GW; Mufson, EJ; Mash, DC; Levey, AI
      Immunocytochemical localization of the dopamine transporter in human brain

      JOURNAL OF COMPARATIVE NEUROLOGY
    15. Miller, GW; Erickson, JD; Perez, JT; Penland, SN; Mash, DC; Rye, DB; Levey, AI
      Immunochemical analysis of vesicular monoamine transporter (VMAT2) proteinin Parkinson's disease

      EXPERIMENTAL NEUROLOGY
    16. PABLO JP; MASH DC
      NORIBOGAINE STIMULATES NALOXONE-SENSITIVE [S-35] GTP-GAMMA-S BINDING

      NeuroReport
    17. DEECHER DC; MASH DC; STALEY JK; MUFSON EJ
      CHARACTERIZATION AND LOCALIZATION OF GALANIN RECEPTORS IN HUMAN ENTORHINAL CORTEX

      Regulatory peptides
    18. OBACH RS; PABLO J; MASH DC
      CYTOCHROME P4502D6 CATALYZES THE O-DEMETHYLATION OF THE PSYCHOACTIVE ALKALOID IBOGAINE TO 12-HYDROXYIBOGAMINE

      Drug metabolism and disposition
    19. MUFSON EJ; MA SY; JAFFAR S; CILIAX BJ; JOYCE J; COCHRAN E; MASH DC; KORDOWER JH; LEVEY AI
      AGE-RELATED-CHANGES IN DOPAMINE TRANSPORTER IMMUNOREACTIVITY WITHIN THE HUMAN SUBSTANTIA-NIGRA - AN UNBIASED STEREOLOGIC EVALUATION

      Journal of neuropathology and experimental neurology
    20. Hulette, CM; Welsh-Bohmer, KA; Murray, MG; Saunders, AM; Mash, DC; McIntyre, LM
      Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    21. EFANGE SMN; MASH DC; KHARE AB; OUYANG QJ
      MODIFIED IBOGAINE FRAGMENTS - SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL CHARACTERIZATION OF 1,2,3,4,5,6-HEXAHYDROAZEPINO[4,5-B]BENZOTHIOPHENES

      Journal of medicinal chemistry
    22. MASH DC
      ARE NEUROADAPTATIONS IN D-3 DOPAMINE-RECEPTORS LINKED TO THE DEVELOPMENT OF COCAINE DEPENDENCE

      Molecular psychiatry
    23. GUILLOZET AL; SMILEY JF; MASH DC; MESULAM MM
      BUTYRYLCHOLINESTERASE IN THE LIFE-CYCLE OF AMYLOID PLAQUES

      Annals of neurology
    24. MILLER GW; STALEY JK; HEILMAN CJ; PEREZ JT; MASH DC; RYE DB; LEVEY AI
      IMMUNOCHEMICAL ANALYSIS OF DOPAMINE TRANSPORTER PROTEIN IN PARKINSONS-DISEASE

      Annals of neurology
    25. STALEY JK; ROTHMAN RB; RICE KC; PARTILLA J; MASH DC
      KAPPA(2) OPIOID RECEPTORS IN LIMBIC AREAS OF THE HUMAN BRAIN ARE UP-REGULATED BY COCAINE IN FATAL OVERDOSE VICTIMS

      The Journal of neuroscience
    26. EFANGE SMN; GARLAND EM; STALEY JK; KHARE AB; MASH DC
      VESICULAR ACETYLCHOLINE TRANSPORTER DENSITY AND ALZHEIMERS-DISEASE

      Neurobiology of aging
    27. SEGAL DM; MORAES CT; MASH DC
      UP-REGULATION OF D-3 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE NUCLEUS-ACCUMBENS OF HUMAN COCAINE FATALITIES

      Molecular brain research
    28. RUTTENBER AJ; LAWLERHEAVNER J; YIN M; WETLI CV; HEARN WL; MASH DC
      FATAL EXCITED DELIRIUM FOLLOWING COCAINE USE - EPIDEMIOLOGIC FINDINGSPROVIDE NEW EVIDENCE FOR MECHANISMS OF COCAINE TOXICITY

      Journal of forensic sciences
    29. STALEY JK; MASH DC; PARSONS SM; KHARE AB; EFANGE SMN
      PHARMACOLOGICAL CHARACTERIZATION OF THE VESAMICOL ANALOG (-[I-125]MIBT IN PRIMATE BRAIN())

      European journal of pharmacology
    30. STALEY JK; TALBOT JZ; CILIAX BJ; MILLER GW; LEVEY AI; KUNG MP; KUNG HF; MASH DC
      RADIOLIGAND BINDING AND IMMUNOAUTORADIOGRAPHIC EVIDENCE FOR A LACK OFTOXICITY TO DOPAMINERGIC NERVE-TERMINALS IN HUMAN COCAINE OVERDOSE VICTIMS

      Brain research
    31. SHAH SM; SHAPSHAK P; RIVERS JE; STEWART RV; WEATHERBY NL; XIN KQ; PAGE JB; CHITWOOD DD; MASH DC; VLAHOV D; MCCOY CB
      DETECTION OF HIV-1 DNA IN NEEDLE SYRINGES, PARAPHERNALIA, AND WASHES FROM SHOOTING GALLERIES IN MIAMI - A PRELIMINARY LABORATORY REPORT

      Journal of acquired immune deficiency syndromes and human retrovirology
    32. MASH DC; STALEY JK; DOEPEL FM; YOUNG SN; ERVIN FR; PALMOUR RM
      ALTERED DOPAMINE TRANSPORTER DENSITIES IN ALCOHOL-PREFERRING VERVET MONKEYS

      NeuroReport
    33. MASH DC; STALEY JK; MUFSON EJ; MITTLEMAN RE; SANCHEZRAMOS J; WEINER WJ
      COCAINE DELIRIUM AND SUDDEN-DEATH - A POSSIBLE COCAINE - VARIANT OF NEUROLEPTIC MALIGNANT SYNDROME

      Annals of neurology
    34. STALEY JK; MASH DC
      ADAPTIVE INCREASE IN D-3 DOPAMINE-RECEPTORS IN THE BRAIN REWARD CIRCUITS OF HUMAN COCAINE FATALITIES

      The Journal of neuroscience
    35. EFANGE SMN; KHARE AB; LANGASON RB; MASH DC
      REGULATION OF CHOLINERGIC SYNAPTIC VESICLE FUNCTION

      The Journal of nuclear medicine
    36. CALLAWAY JC; RAYMON LP; HEARN WL; MCKENNA DJ; GROB CS; BRITO GS; MASH DC
      QUANTITATION OF N,N-DIMETHYLTRYPTAMINE AND HARMALA ALKALOIDS IN HUMANPLASMA AFTER ORAL DOSING WITH AYAHUASCA

      Journal of analytical toxicology
    37. STALEY JK; ROTHMAN RB; RICE KC; SANCHEZRAMOS J; WEINER WJ; MASH DC
      MAPPING THE DISTRIBUTION OF KAPPA-2 OPIOID RECEPTORS IN PARKINSONS-DISEASE - A LIGAND-BINDING AND AUTORADIOGRAPHY STUDY

      Neurology
    38. STALEY JK; OUYANG Q; PABLO J; HEARN WL; FLYNN DD; ROTHMAN RB; RICE KC; MASH DC
      PHARMACOLOGICAL SCREEN FOR ACTIVITIES OF 12-HYDROXYIBOGAMINE - A PRIMARY METABOLITE OF THE INDOLE ALKALOID IBOGAINE

      Psychopharmacology
    39. FERRARIDILEO G; MASH DC; FLYNN DD
      ATTENUATION OF MUSCARINIC RECEPTOR-G-PROTEIN INTERACTION IN ALZHEIMER-DISEASE

      Molecular and chemical neuropathology
    40. BAUMANN MH; MASH DC; STALEY JK
      THE SEROTONIN AGONIST M-CHLOROPHENYLPIPERAZINE (MCPP) BINDS TO SEROTONIN TRANSPORTER SITES IN HUMAN BRAIN

      NeuroReport
    41. STALEY JK; BOJA JW; CARROLL FI; SELTZMAN HH; WYRICK CD; LEWIN AH; ABRAHAM P; MASH DC
      MAPPING DOPAMINE TRANSPORTERS IN THE HUMAN BRAIN WITH NOVEL SELECTIVECOCAINE ANALOG [I-125] RTI-121

      Synapse
    42. MASH DC; STALEY JK; PABLO JP; HOLOHEAN AM; HACKMAN JC; DAVIDOFF RA
      PROPERTIES OF IBOGAINE AND ITS PRINCIPAL METABOLITE (12-HYDROXYIBOGAMINE) AT THE MK-801 BINDING-SITE OF THE NMDA RECEPTOR COMPLEX

      Neuroscience letters
    43. HEARN WL; PABLO J; HIME GW; MASH DC
      IDENTIFICATION AND QUANTITATION OF IBOGAINE AND AN O-DEMETHYLATED METABOLITE IN BRAIN AND BIOLOGICAL-FLUIDS USING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY

      Journal of analytical toxicology
    44. MASH DC; STALEY JK; KUNG MP; KUNG HF; WEINER WJ
      VISUALIZING THE HUMAN VESICULAR MONOAMINE TRANSPORTER IN-VITRO WITH I-125 IODOVINYLTETRA-BENAZINE

      Neurology
    45. MASH DC; STALEY JK; BAUMANN MH; ROTHMAN RB; HEARN WL
      IDENTIFICATION OF A PRIMARY METABOLITE OF IBOGAINE THAT TARGETS SEROTONIN TRANSPORTERS AND ELEVATES SEROTONIN

      Life sciences
    46. FLYNN DD; FERRARIDILEO G; LEVEY AI; MASH DC
      DIFFERENTIAL ALTERATIONS IN MUSCARINIC RECEPTOR SUBTYPES IN ALZHEIMERS-DISEASE - IMPLICATIONS FOR CHOLINERGIC-BASED THERAPIES

      Life sciences
    47. FLYNN DD; FERRARIDILEO G; MASH DC; LEVEY AI
      DIFFERENTIAL REGULATION OF MOLECULAR SUBTYPES OF MUSCARINIC RECEPTORSIN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    48. MASH DC; DOUYON R; HEARN WL; SAMBOL NC; SANCHEZRAMOS J
      A PRELIMINARY-REPORT ON THE SAFETY AND PHARMACOKINETICS OF IBOGAINE

      Biological psychiatry
    49. STALEY JK; WETLI CV; RUTTENBER AJ; HEARN WL; KUNG HF; MASH DC
      DOPAMINE TRANSPORTER AND RECEPTOR AUTORADIOGRAPHY IN COCAINE PSYCHOSIS AND SUDDEN-DEATH

      Biological psychiatry
    50. BAGHDOYAN HA; MALLIOS VJ; DUCKROW RB; MASH DC
      LOCALIZATION OF MUSCARINIC RECEPTOR SUBTYPES IN BRAIN-STEM AREAS REGULATING SLEEP

      NeuroReport
    51. SHAPSHAK P; MCCOY CB; SHAH SM; PAGE JB; RIVERS JE; WEATHERBY NL; CHITWOOD DD; MASH DC
      PRELIMINARY LABORATORY STUDIES OF INACTIVATION OF HIV-1 IN NEEDLES AND SYRINGES CONTAINING INFECTED BLOOD USING UNDILUTED HOUSEHOLD BLEACH

      Journal of acquired immune deficiency syndromes
    52. GEULA C; MASH DC; MESULAM MM
      LOSS OF CORTICAL CHOLINERGIC FIBERS IN ALZHEIMERS-DISEASE - LACK OF ARELATIONSHIP WITH AMYLOID DEPOSITS BUT A MODEST RELATIONSHIP WITH TANGLE DENSITY

      Neurobiology of aging
    53. MASH DC; SINGER J; PABLO J; BRUCE J; WEINER WJ
      DIFFERENTIAL REGULATION OF IRON STORAGE AND TRANSPORT MARKERS IN PARKINSONS-DISEASE

      Neurology
    54. FERRARIDILEO G; WAELBROECK M; MASH DC; FLYNN DD
      SELECTIVE LABELING AND LOCALIZATION OF THE M4 (M4) MUSCARINIC RECEPTOR SUBTYPE

      Molecular pharmacology
    55. ZABETIAN CP; STALEY JK; FLYNN DD; MASH DC
      [H-3]-(-PENTAZOCINE BINDING TO SIGMA-RECOGNITION SITES IN HUMAN 12REBELLUM())

      Life sciences
    56. STALEY JK; HEARN WL; RUTTENBER AJ; WETLI CV; MASH DC
      HIGH-AFFINITY COCAINE RECOGNITION SITES ON THE DOPAMINE TRANSPORTER ARE ELEVATED IN FATAL COCAINE OVERDOSE VICTIMS

      The Journal of pharmacology and experimental therapeutics
    57. STALEY JK; BASILE M; FLYNN DD; MASH DC
      VISUALIZING DOPAMINE AND SEROTONIN TRANSPORTERS IN THE HUMAN BRAIN WITH THE POTENT COCAINE ANALOG [I-125] RTI-55 - IN-VITRO BINDING AND AUTORADIOGRAPHIC CHARACTERIZATION

      Journal of neurochemistry
    58. CHAKKO S; SEPULVEDA S; KESSLER KM; SOTOMAYOR MC; MASH DC; PRINEAS RJ; MYERBURG RJ
      FREQUENCY AND TYPE OF ELECTROCARDIOGRAPHIC ABNORMALITIES IN COCAINE ABUSERS (ELECTROCARDIOGRAM IN COCAINE ABUSE)

      The American journal of cardiology
    59. PALMOUR RM; ERVIN FR; GRBAVIC D; STALEY J; MASH DC
      BIOLOGICAL MARKERS AND GENETIC VULNERABILITY IN ALCOHOL-PREFERRING VERVET MONKEYS

      Neuropsychopharmacology
    60. FLYNN DD; MASH DC
      DISTINCT KINETIC BINDING-PROPERTIES OF N-H-3!-METHYLSCOPOLAMINE AFFORD DIFFERENTIAL LABELING AND LOCALIZATION OF M1, M2, AND M3-MUSCARINIC-RECEPTOR SUBTYPES IN PRIMATE BRAIN

      Synapse
    61. FLYNN DD; SANCHEZRAMOS L; MASH DC
      PERINATAL COCAINE EXPOSURE ALTERS SIGMA BINDING-SITE DENSITY IN THE PLACENTA

      Research communications in substance abuse
    62. EMRE M; HECKERS S; MASH DC; GEULA C; MESULAM MM
      CHOLINERGIC INNERVATION OF THE AMYGDALOID COMPLEX IN THE HUMAN BRAIN AND ITS ALTERATIONS IN OLD-AGE AND ALZHEIMERS-DISEASE

      Journal of comparative neurology
    63. MESULAM MM; HERSH LB; MASH DC; GEULA C
      DIFFERENTIAL CHOLINERGIC INNERVATION WITHIN FUNCTIONAL SUBDIVISIONS OF THE HUMAN CEREBRAL-CORTEX - A CHOLINE-ACETYLTRANSFERASE STUDY

      Journal of comparative neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 17:26:01